| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | ||
|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||
Net loss for the period | ||||||
-61,469 | -39,027 | -31,208 | -24,243 | -22,006 | ||
Adjustments to reconcile net loss to net cash (used in) from operating activities: | ||||||
Depreciation | ||||||
2,800 | 2,000 | 1,500 | 1,193 | 986 | ||
Amortization of intangible assets | ||||||
5,300 | 2,500 | 600 | 314 | 482 | ||
Amortization of debt discount and issuance costs | ||||||
1,500 | - | - | - | - | ||
Unrealized (gain) loss foreign exchange | ||||||
-617 | -134 | -1,751 | 2,486 | 162 | ||
Accrued interest on convertible debt | ||||||
806 | - | - | - | - | ||
Non-cash finance costs | ||||||
- | - | - | 85 | 74 | ||
Share-based compensation | ||||||
33,792 | 20,837 | 6,280 | 2,994 | 2,357 | ||
Provisions | ||||||
- | - | - | - | 160 | ||
Deferred income taxes | ||||||
- | 327 | - | - | - | ||
Income tax for the period | ||||||
149 | -323 | 324 | 63 | -7 | ||
Income tax (paid) received | ||||||
- | - | - | - | -63 | ||
Changes in operating assets and liabilities: | ||||||
Accounts receivable | ||||||
13,623 | 12,387 | 16,533 | 12,545 | -11,865 | ||
Trade and other payables | ||||||
- | - | - | - | 4,741 | ||
Other assets | ||||||
8,513 | 6,435 | 1,747 | 1,524 | 1,585 | ||
Accounts payable | ||||||
-1,286 | 1,643 | 727 | - | - | ||
Accrued expenses and other current liabilities | ||||||
5,758 | 9,987 | 6,902 | - | - | ||
Accounts payable, accrued expenses and other current liabilities | ||||||
- | - | - | 6,753 | - | ||
Contract liabilities - deferred revenue | ||||||
19,729 | 24,778 | 29,089 | 32,769 | 13,289 | ||
Operating lease liabilities | ||||||
-85 | - | - | - | - | ||
Net cash from (used in) operating activities | ||||||
-14,517 | 3,435 | -2,321 | 3,373 | -9,979 | ||
Cash flows from investing activities: | ||||||
Acquisition of property and equipment | ||||||
2,191 | 5,006 | 2,224 | 1,417 | 788 | ||
Cash consideration for business acquisition, net of cash acquired | ||||||
- | 59,493 | 9,189 | - | - | ||
Net cash used in investing activities | ||||||
-2,191 | -64,499 | -11,413 | -1,417 | -788 | ||
Cash flows from financing activities: | ||||||
Proceeds from issuance of convertible senior notes, net of issuance costs | ||||||
147,498 | - | - | - | - | ||
Proceeds from issuance of ordinary shares upon initial public offering, net of offering costs and underwriters commissions and discounts | ||||||
- | - | - | 91,818 | - | ||
Proceeds from issuance of ordinary shares related to exercise of stock awards | ||||||
5,805 | 7,053 | 6,672 | 926 | - | ||
Proceeds from issuance of ordinary shares related to employee stock purchase plan | ||||||
4,738 | 1,805 | - | - | 1,631 | ||
Proceeds from borrowings | ||||||
- | - | - | 2,000 | 9,914 | ||
Repayment of borrowings | ||||||
203 | 242 | 153 | 12,142 | 2,616 | ||
Prepayment fee under Square 1 loan | ||||||
- | - | - | 267 | - | ||
Net cash from financing activities | ||||||
157,838 | 8,616 | 6,519 | 82,335 | 8,929 | ||
Net increase (decrease) in cash and cash equivalents | ||||||
141,130 | -52,448 | -7,215 | 84,291 | -1,838 | ||
Effect of exchange rate changes on cash and cash equivalents | ||||||
1,841 | -836 | 3,216 | -198 | -422 | ||
Supplemental disclosures | ||||||
Cash paid for income taxes | ||||||
377 | 302 | 158 | 172 | - | ||
Cash paid for interest | ||||||
- | - | - | 461 | - | ||